glp 1 alzheimer's research Glucagon like peptide-1 (GLP-1) likes disease Neuroprotective Actions of Glucagon-Like Peptide-1

Saleh MG, Oeltzschner G, Chan KL, Puts NAJ, Mikkelsen M, Schr M, et al

DARPins can selectively bind any given target protein with high affinity 30 , and HSA can be specifically targeted by albumin-binding DARPin too

DOI: 10.1210/jcemcr/luac014.036 Singh, A., Haq, N., Yang, M., Luckey, S., Mansouri, S., Campbell-Thompson, M., Jin, L., Christou-Savina, S., & de Lartigue, G

Collectively, these data highlight combined sertraline/chloroquine treatment as a novel targeted therapy for ser/gly-producing GBMs under hypoxia and low glucose levels, i.e., conditions that reflect the physiological aspects of the GBM microenvironment